سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

Molecular Simulations Identify Target Receptor Kinases Bound by Astaxanthin to Induce Breast Cancer Cell Apoptosis

Publish Year: 1399
Type: Journal paper
Language: English
View: 480

This Paper With 11 Page And PDF Format Ready To Download

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

Export:

Link to this Paper:

Document National Code:

JR_ARCHB-7-2_009

Index date: 14 June 2021

Molecular Simulations Identify Target Receptor Kinases Bound by Astaxanthin to Induce Breast Cancer Cell Apoptosis abstract

Background: We investigated molecular mechanisms behind astaxanthinmediatedinduction of apoptosis in breast cancer cell lines toward combinationtherapy against cancer drug resistance. Methods: Breast cancer cell lines were treated with serial concentrations ofastaxanthin to determine its IC50. We used drug-design software to predictinteractions between astaxanthin and receptor tyrosine kinases or other key geneproducts involved in intracellular signaling pathways. Changes in gene expressionwere examined using RT-PCR. The effect of astaxanthin-nanocarbonscombinations on cancer cells was also evaluated. Results: Astaxanthin induced cell death in all three breast cancer cell lines wasexamined so that its IC50 in two HER2-amplifying lines SKBR3 and BT-474stood, respectively, at 36 and 37 μM; however, this figure for MCF-7 wassignificantly lowered to 23 μM (P<0.05). Astaxanthin-treated SKBR3 cellsshowed apoptotic death upon co-staining. Our in silico examinations showed thatsome growth-promoting molecules are strongly bound by astaxanthin via theirspecific amino acid residues with their binding energy standing below -6KCa/Mol. Next, astaxanthin was combined with either graphene oxide orcarboxylated multi-walled carbon nanotube, with the latter affecting SKBR cellsurvival more extensively than the former (P<0.05). Finally, astaxanthin coinducedtumor suppressors p53 and PTEN but downregulated the expression ofgrowth-inducing genes in treated cells.Conclusions: These findings indicate astaxanthin carries' multitarget antitumorigeniccapacities and introduce the compound as a suitable candidate forcombination therapy regimens against cancer growth and drug resistance.Development of animal models to elucidate interactions between the compoundand tumor microenvironment could be a major step forward towards the inclusionof astaxanthin in cancer therapy trials.

Molecular Simulations Identify Target Receptor Kinases Bound by Astaxanthin to Induce Breast Cancer Cell Apoptosis Keywords:

Molecular Simulations Identify Target Receptor Kinases Bound by Astaxanthin to Induce Breast Cancer Cell Apoptosis authors

Mossa Gardaneh

Department of Stem Cells and Regenerative Medicine, Division of Medical Biotechnology, National Institute ofGenetic Engineering and Biotechnology, Tehran, Iran

Zahra Nayeri

Department of Stem Cells and Regenerative Medicine, Division of Medical Biotechnology, National Institute ofGenetic Engineering and Biotechnology, Tehran, Iran

Parvin Akbari

Department of Stem Cells and Regenerative Medicine, Division of Medical Biotechnology, National Institute ofGenetic Engineering and Biotechnology, Tehran, Iran

Mahsa Gardaneh

Department of Biology, York University, Toronto, Canada

Hasan Tahermansouri

Department of Chemistry, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran